(Q68472325)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

title

Ifosfamide and mesna in combination with other cytostatic drugs in the treatment of patients with advanced cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

1 reference

G Falkson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

M R Chasen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

H C Falkson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 May 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

24 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

page(s)

215-219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00177264

24 September 2019

exact match

0 references

cites work

Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector

1 reference

12 December 2020

A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma

1 reference

12 December 2020

1 reference

12 December 2020

Ifosfamide in experimental tumor systems

1 reference

12 December 2020

Ifosfamide in small cell lung cancer.

1 reference

12 December 2020

Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults

1 reference

12 December 2020

Dosing and sequencing for antineoplastic synergism in combination chemotherapy

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Unexpected toxicity in patients treated with iphosphamide

1 reference

12 December 2020

Alternatives to CYVADIC-combination therapy of soft tissue sarcomas

1 reference

12 December 2020

Further experience with isophosphamide

1 reference

12 December 2020

Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment

1 reference

12 December 2020

Ifosfamide treatment of advanced ovarian cancer

1 reference

12 December 2020

Ifosfamide in refractory male germ cell tumors

1 reference

12 December 2020

Ifosfamide plus mesna with and without adriamycin in soft tissue sarcoma

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00177264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2166721%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference